X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Algorithmic assessment of cellular senescence in experimental and clinical specimens.

J Kohli | B Wang | S M Brandenburg | N Basisty | K Evangelou | M Varela-Eirin | J Campisi | B Schilling | V Gorgoulis | M Demaria
Nature protocols | 2021

The development of genetic tools allowed for the validation of the pro-aging and pro-disease functions of senescent cells in vivo. These discoveries prompted the development of senotherapies-pharmaceutical interventions aimed at interfering with the detrimental effect of senescent cells-that are now entering the clinical stage. However, unequivocal identification and examination of cellular senescence remains highly difficult because of the lack of universal and specific markers. Here, to overcome the limitation of measuring individual markers, we describe a detailed two-phase algorithmic assessment to quantify various senescence-associated parameters in the same specimen. In the first phase, we combine the measurement of lysosomal and proliferative features with the expression of general senescence-associated genes to validate the presence of senescent cells. In the second phase we measure the levels of pro-inflammatory markers for specification of the type of senescence. The protocol can help graduate-level basic scientists to improve the characterization of senescence-associated phenotypes and the identification of specific senescent subtypes. Moreover, it can serve as an important tool for the clinical validation of the role of senescent cells and the effectiveness of anti-senescence therapies.

Pubmed ID: 33911261 RIS Download

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: R01 AG051729
  • Agency: NIA NIH HHS, United States
    Id: K99 AG065484
  • Agency: NIH HHS, United States
    Id: S10 OD028654
  • Agency: NIA NIH HHS, United States
    Id: U01 AG060906
  • Agency: NIA NIH HHS, United States
    Id: P01 AG017242

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-Biotin antibody [Hyb-8] (antibody)

RRID:AB_2861249

This monoclonal targets Biotin

View all literature mentions

p21 (M-19) (antibody)

RRID:AB_632123

This polyclonal targets p21 (M-19)

View all literature mentions

Recombinant Anti-Ki67 antibody [SP6] (antibody)

RRID:AB_302459

This recombinant monoclonal targets Ki67

View all literature mentions

BJ [Human fibroblast] (cell line)

RRID:CVCL_3653

Cell line BJ [Human fibroblast] is a Finite cell line with a species of origin Homo sapiens (Human)

View all literature mentions